Dear Respiratory friends, we are happy to present our new article: Management of Stable COPD: An Update 2014 from Current Respiratory Medicine Reviews! Free for download!
http://benthamscience.com/journal/abstracts.php?journalID=crmr&articleID=120557
ABSTRACT Chronic obstructive pulmonary disease (COPD)
is a major problem for public health worldwide and an important cause of
morbidity and mortality at the global level. Its burden is expected to
increase progressively in the next years. This article summarizes the
most current aspects of the non-pharmacological and pharmacological
treatment of stable COPD. Non-pharmacological therapies, such as smoking
cessation, vaccinations, oxygen therapy and pulmonary rehabilitation
are covered briefly. Drug classes covered are short acting beta agonists
(SABA), short acting muscarinic antagonists (SAMA), long acting beta
agonists (LABA), long acting antimuscarinics (LAMA), inhaled
corticosteroids (ICS), LABA/ICS combinations and specific
phosphodiesterase (PDE4) inhibitors.
No comments:
Post a Comment